HYPE: Pumpkin seed oil blocks DHT and regrows hair as effectively as established hair-loss treatments.
But what does the evidence actually show?
There are encouraging small human studies, including an oral trial in men and a topical comparison in women. They do not establish dependable regrowth across products or equivalence to minoxidil. The oral and topical routes must be assessed separately, and a reported percentage increase in a counted area is not a percentage of bald scalp restored.
Why people believe this
The proposed mechanism involves phytosterols and the enzyme that converts testosterone into DHT. DHT contributes to follicle miniaturisation in susceptible people with pattern hair loss. Animal findings make the hypothesis plausible, but they do not prove that a shop-bought oil meaningfully lowers scalp DHT or reverses hair loss in people.
Hair loss also has different causes. Pattern thinning, temporary shedding, inflammation and nutritional problems are not one condition. Results in a diagnosed study group cannot establish a treatment for every person who notices fewer hairs.
What does the evidence show?
The strongest reasonable case comes from measured human hair outcomes rather than testimonials or an attractive mechanism. Two often-cited trials provide a signal, with important limits.
A promising oral study in 76 men
Cho and colleagues assigned men with mild-to-moderate pattern hair loss to a study supplement described as 400 mg/day pumpkin seed oil or placebo for 24 weeks. Average hair counts rose about 40% from baseline with the active product and about 10% with placebo. The finding concerns the measured scalp area, not complete restoration of hair coverage. Adverse-event reports did not differ detectably.
Topical oil showed a signal, but equivalence was not tested
Sixty women were allocated to topical pumpkin seed oil or 5% minoxidil foam for three months. Dermoscopic measures improved within both groups. Improvement from baseline is not a demonstration that the treatments work equally well: an adequately designed non-inferiority comparison, suitable margin and precision would be needed.
The catch: product, route and outcome
The 2014 report used a named commercial capsule preparation. Its result should not be assumed to apply to culinary oil, every supplement, a shampoo or topical application. The study describes its intervention as pumpkin seed oil, but provides insufficient formulation detail for us to attribute every observed effect to a universally identical retail product.
The male oral trial and female topical trial studied different populations, exposures and follow-up periods. Combining them into one percentage promise would hide those differences. Small studies also have limited ability to detect uncommon adverse effects or establish long-term safety.
Statistical significance does not settle practical value. Readers need to know whether the change is visible, sustained and important to them, not merely whether a counted field improved. Larger independent trials with standardised products and long-term follow-up would increase confidence.
Is it as effective as minoxidil?
The available evidence does not support that conclusion. A comparison study in which both groups improve is not a reliable shortcut to equivalence. Established treatment also has a wider clinical evidence base. See our minoxidil investigation for that separate assessment.
Avoid transferring a rosemary-oil finding to pumpkin seed oil simply because both are oils. They contain different compounds and have different trial histories.
Safety and assessment
Oil can irritate skin, and supplements may have ingredients other than the one on the front label. A small trial without a clear adverse-event difference cannot rule out rare reactions or interactions. Sudden, patchy, painful or otherwise unexplained hair loss warrants assessment of the cause rather than repeated product experiments.
The doses reported above describe research, not a personalised recommendation. Eating pumpkin seeds is a food choice; it has not been established as an equivalent hair-loss treatment by these trials.
What this means for you
Treat pumpkin seed oil as a preliminary option rather than a dependable substitute for assessed treatment. If discussing it with a clinician, identify the route and exact formulation, and use realistic expectations.
The useful finding is a human signal worth replicating. It does not justify promising 40% more hair to every user or saying a topical oil matches minoxidil.
Encouraging small trials. Reliable regrowth and treatment equivalence remain unconfirmed.
Research & Sources
1. Cho et al. (2014). Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: randomised, double-blind, placebo-controlled trial. Published record and accessible report text assessed.
2. Pumpkin seed oil vs. minoxidil 5% topical foam for female pattern hair loss: randomised comparative trial (2021). Published abstract assessed.
Evidence reviewed: October 2026
This targeted editorial review assessed research available on 13 October 2026; it is not an exhaustive systematic review. Abstract-only assessments are identified in the sources. Evidence vs Hype provides education, not individual diagnosis or treatment. Featured artwork is conceptual, not a study result. No commercial product was selected or endorsed for this investigation.